CLDN6 and non-small cell lung carcinoma: Claudin-6 was significantly more frequent and most abundantly positive in adenocarcinoma (AC) than in squamous cell carcinoma (SCC), and was associated with poor prognosis in 164 patients with NSCLC from the University Hospital of Kuopio (Oini et al., 2022).